Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03593694 · ClinicalTrials.gov registry record · NA
Technology Delivered Diabetes-Modified Behavioral Activation Treatment
A NA study, sponsored by State University of New York at Buffalo.
- Terminated
- Registry status
- NA
- Development phase
- 30
- Enrollment target
NCT03593694 is a NA study that was terminated before completion, run by State University of New York at Buffalo. The registered enrollment target is 30 participants.
The verdict
NCT03593694, a NA study, was terminated before completion, sponsored by State University of New York at Buffalo.
- TERMINATED
- Registry status
- NA
- Development phase
- 30 participants
- Enrollment target
Study Summary
The overarching goal of this proposal is to test the efficacy of a multi-component, high intensity intervention, technology delivered, diabetes-modified behavioral activation treatment (TECH DM-BAT) that incorporates: 1) diabetes education; 2) home telemonitoring; and 3) diabetes modified behavioral activation, delivered by nurses via smartphones is effective in improving metabolic control in African Americans with poorly controlled type 2 diabetes.
Interventions
- BEHAVIORAL TECH DM-BAT
- BEHAVIORAL TECH DMBAT Active Comparator
- BEHAVIORAL TECH DMBAT Other
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2017-11-06 |
| Est. Completion | 2019-04-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03593694
The ClinicalTrials.gov registry entry for NCT03593694 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is State University of New York at Buffalo, which has 243 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which TECH DM-BAT is the first listed.
NCT03593694 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03593694 about?
NCT03593694 is a clinical study titled "Technology Delivered Diabetes-Modified Behavioral Activation Treatment". The overarching goal of this proposal is to test the efficacy of a multi-component, high intensity intervention, technology delivered, diabetes-modified behavioral activation treatment (TECH DM-BAT) that incorporates: 1) diabetes education; 2) home telemonitoring; and 3) diabetes modified behavioral...
What is the current status of trial NCT03593694?
This trial is currently terminated. It is a NA study. The enrollment target is 30 participants. The study started on 2017-11-06. Estimated completion is 2019-04-30.
What interventions are being tested in trial NCT03593694?
The interventions under investigation include: TECH DM-BAT (BEHAVIORAL), TECH DMBAT Active Comparator (BEHAVIORAL), TECH DMBAT Other (BEHAVIORAL).
Who is sponsoring clinical trial NCT03593694?
This trial is sponsored by State University of New York at Buffalo, which has 243 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.